Cervical cancer prevention

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 500,000 new cases each year (WHO Report 2006). Most of these cases (90%) occur in the developing world where it is the second most common malignancy in women after breast cancer (WHO Report 2006). By contrast, in the United States (U.S.) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health care services. In the U.S., an individual woman's lifetime risk of developing cervical cancer is estimated to be 1 in 142 (Ries et al. 2007). In 2008, it is estimated that there were approximately 11,070 new cases of cervical cancer, and 3,870 deaths in the U.S. (Jemal et al. 2008).

Original languageEnglish (US)
Title of host publicationFundamentals of Cancer Prevention
PublisherSpringer Berlin Heidelberg
Pages423-445
Number of pages23
ISBN (Print)9783540242123
DOIs
StatePublished - 2005

Fingerprint

Uterine Cervical Neoplasms
Papanicolaou Test
Neoplasms
Health Services Accessibility
Health Services
Breast Neoplasms
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Garcia, F. A., Nuno, T., & Mitchell, A. L. (2005). Cervical cancer prevention. In Fundamentals of Cancer Prevention (pp. 423-445). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-68986-7_16

Cervical cancer prevention. / Garcia, Francisco A; Nuno, T.; Mitchell, Amy L.

Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. p. 423-445.

Research output: Chapter in Book/Report/Conference proceedingChapter

Garcia, FA, Nuno, T & Mitchell, AL 2005, Cervical cancer prevention. in Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, pp. 423-445. https://doi.org/10.1007/978-3-540-68986-7_16
Garcia FA, Nuno T, Mitchell AL. Cervical cancer prevention. In Fundamentals of Cancer Prevention. Springer Berlin Heidelberg. 2005. p. 423-445 https://doi.org/10.1007/978-3-540-68986-7_16
Garcia, Francisco A ; Nuno, T. ; Mitchell, Amy L. / Cervical cancer prevention. Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. pp. 423-445
@inbook{dd51388d990e46ef97e7a5d6c08bbe3e,
title = "Cervical cancer prevention",
abstract = "Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 500,000 new cases each year (WHO Report 2006). Most of these cases (90{\%}) occur in the developing world where it is the second most common malignancy in women after breast cancer (WHO Report 2006). By contrast, in the United States (U.S.) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health care services. In the U.S., an individual woman's lifetime risk of developing cervical cancer is estimated to be 1 in 142 (Ries et al. 2007). In 2008, it is estimated that there were approximately 11,070 new cases of cervical cancer, and 3,870 deaths in the U.S. (Jemal et al. 2008).",
author = "Garcia, {Francisco A} and T. Nuno and Mitchell, {Amy L}",
year = "2005",
doi = "10.1007/978-3-540-68986-7_16",
language = "English (US)",
isbn = "9783540242123",
pages = "423--445",
booktitle = "Fundamentals of Cancer Prevention",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Cervical cancer prevention

AU - Garcia, Francisco A

AU - Nuno, T.

AU - Mitchell, Amy L

PY - 2005

Y1 - 2005

N2 - Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 500,000 new cases each year (WHO Report 2006). Most of these cases (90%) occur in the developing world where it is the second most common malignancy in women after breast cancer (WHO Report 2006). By contrast, in the United States (U.S.) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health care services. In the U.S., an individual woman's lifetime risk of developing cervical cancer is estimated to be 1 in 142 (Ries et al. 2007). In 2008, it is estimated that there were approximately 11,070 new cases of cervical cancer, and 3,870 deaths in the U.S. (Jemal et al. 2008).

AB - Cervical cancer is the most common gynecologic malignancy worldwide, accounting for about 500,000 new cases each year (WHO Report 2006). Most of these cases (90%) occur in the developing world where it is the second most common malignancy in women after breast cancer (WHO Report 2006). By contrast, in the United States (U.S.) cervical cancer has decreased dramatically since the introduction of cytologic screening (Pap smear), and is now a relatively infrequent neoplasm, especially among well-screened majority populations with access to health care services. In the U.S., an individual woman's lifetime risk of developing cervical cancer is estimated to be 1 in 142 (Ries et al. 2007). In 2008, it is estimated that there were approximately 11,070 new cases of cervical cancer, and 3,870 deaths in the U.S. (Jemal et al. 2008).

UR - http://www.scopus.com/inward/record.url?scp=84890007810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890007810&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-68986-7_16

DO - 10.1007/978-3-540-68986-7_16

M3 - Chapter

AN - SCOPUS:84890007810

SN - 9783540242123

SP - 423

EP - 445

BT - Fundamentals of Cancer Prevention

PB - Springer Berlin Heidelberg

ER -